Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01786785
Other study ID # 11-008442
Secondary ID K12NS049453
Status Completed
Phase
First received
Last updated
Start date February 2012
Est. completion date October 22, 2016

Study information

Verified date April 2022
Source Children's Hospital of Philadelphia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute ischemic stroke affects roughly 1 in 50,000 children every year and is one of the top ten causes of death in children. Currently, caregivers lay the affected child flat in hopes of increasing blood flow to the brain and reducing the volume of the brain which is damaged. However, there are currently no techniques to measure brain blood flow at the child's bedside and indicate if this treatment is effective. We will probe brain blood volume, oxygen saturation, and flow with red light to determine the efficacy of this intervention.


Description:

Arterial ischemic stroke (AIS) affects about 2 children per 100,000 per year and is one of the top 10 causes of mortality in children. After stroke, there is a disturbance in cerebral blood flow (CBF) autoregulation, and changes in head position may change CBF. Currently, practice at the Children's Hospital of Philadelphia (CHOP) is to keep the head of bed (HOB) of a child with AIS flat for 24 hours; however, there is no evidence that this practice is efficacious in children. Furthermore, maintaining a child supine for 24 hours is uncomfortable for the child and is often unenforceable in younger children. This study will use a noninvasive optical technique to measure CBF as HOB position is changed to assess the effectiveness of head of bed position in increasing CBF in children with acute arterial ischemic stroke. The primary objectives are to determine the difference in CBF at HOB flat (0 degrees) and HOB at +30 degrees in healthy children and in children with AIS. The secondary objectives are to examine CBF in healthy children and in children with AIS at other HOB angles (0, +15, and +30 degrees) compared to the CBF at HOB 0 degrees and to determine if the position that maximizes CBF varies over time from stroke onset.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date October 22, 2016
Est. primary completion date October 22, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria Healthy Control Subjects 1. Subjects age 2-18 years inclusive 2. No history of congenital or acquired brain injury 3. No history of developmental delay, mental retardation, genetic or metabolic syndrome affecting the brain Inclusion Criteria AIS Subjects 1. Subjects age 2-18 years inclusive 2. 72 hours or less from stroke onset 3. MRI or CT confirmation of AIS Exclusion Criteria for All Subjects 1. Skull defect preventing application of probes 2. Moyamoya disease 3. Sickle cell anemia

Study Design


Locations

Country Name City State
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania

Sponsors (5)

Lead Sponsor Collaborator
Children's Hospital of Philadelphia Alavi-Dabiri Postdoctoral Fellowship Award, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Thrasher Research Fund

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in microvascular blood flow in supine position Microvascular blood flow will be measured at 24, 48, and 72 hours post stroke, with the head of bed at 30, 15, and 0 deg (supine). Current clinical practice is to lower the head of bed to the supine position to increase blood flow. 72 hours post stroke